SEC Form 3 · accession 0001493152-17-003301
VBI Vaccines Inc/BC · VBIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Egidio Nascimento
Officer — Chief Financial Officer
Period of report
Dec 31, 2016
Accepted (ET)
Mar 31, 2017 · 7:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000764195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par value per share | holding | — | — | — | 2,968 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (Right to Buy Common Shares)F5,F1 | $2.94 | holding | — | — | — | — | Mar 18, 2018 | Common Shares | 4,671 | — | D |
| Option (Right to Buy Common Shares)F5,F1 | $4.87 | holding | — | — | — | — | Jan 21, 2019 | Common Shares | 13,519 | — | D |
| Option (Right to Buy Common Shares)F5,F1 | $2.94 | holding | — | — | — | — | Mar 29, 2022 | Common Shares | 5,357 | — | D |
| Option (Right to Buy Common Shares)F5,F1 | $2.94 | holding | — | — | — | — | Apr 2, 2022 | Common Shares | 5,357 | — | D |
| Option (Right to Buy Common Shares)F5,F2 | $4.51 | holding | — | — | — | — | Jul 25, 2024 | Common Shares | 153,106 | — | D |
| Option (Right to Buy Common Shares)F5,F3 | $4.74 | holding | — | — | — | — | Jul 30, 2025 | Common Shares | 78,031 | — | D |
| Option (Right to Buy Common Shares)F5,F6,F4 | $3.90 | holding | — | — | — | — | Jun 22, 2026 | Common Shares | 75,000 | — | D |
Explanation of responses
- F1The option is fully vested.
- F2The option vests 1/48th of the total shares monthly following the grant date of July 25, 2014, subject to continued service through each vesting date.
- F3The option vests 1/48th of the total shares monthly following the grant date of July 30, 2015, subject to continued service through each vesting date.
- F4The option vests 1/48th of the total shares monthly following the grant date of June 22, 2016, subject to continued service through each vesting date.
- F5Exercise price is in Canadian dollars, United States dollars equivalent is shown using the closing foreign exchange rate on December 31, 2016.
- F6The original exercise price of USD $3.65 was changed by the Issuer's board of directors to USD $3.90 to reflect the correct exercise price as calculated in accordance with the Issuer's Incentive Plan.